Dezhan Healthcare Company Limited (SHE:000813)
China · Delayed Price · Currency is CNY 3.230
+0.030 (0.94%)
Sep 30, 2026, 3:04 PM CST
Dezhan Healthcare Company Revenue
Dezhan Healthcare Company had revenue of 54.01M CNY in the quarter ending June 30, 2026, a decrease of -29.93%. This brings the company's revenue in the last twelve months to 373.09M, down -2.97% year-over-year. In the year 2025, Dezhan Healthcare Company had annual revenue of 396.81M, down -14.94%.
Revenue (ttm)
373.09M
Revenue Growth
-2.97%
P/S Ratio
18.16
Revenue / Employee
349.66K
Employees
1,067
Market Cap
6.77B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 396.81M | -69.68M | -14.94% |
| Dec 31, 2024 | 466.49M | -31.60M | -6.34% |
| Dec 31, 2023 | 498.09M | -72.77M | -12.75% |
| Jan 1, 2023 | 570.86M | -163.62M | -22.28% |
| Jan 1, 2022 | 734.48M | -228.39M | -23.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| China Animal Husbandry Industry | 6.58B |
| Northeast Pharmaceutical Group | 6.56B |
| Cisen Pharmaceutical | 3.40B |
| Jiangsu Kanion Pharmaceutical | 3.31B |
| Sunflower Pharmaceutical Group | 2.51B |
| Hubei Hongyuan Pharmaceutical Technology | 2.40B |
| Guilin Sanjin Pharmaceutical | 2.02B |
| Jinghua Pharmaceutical Group | 1.48B |